CDH13 and melanoma: Ectopic BRN2 expression in BRN2-deficient/T-cadherin-positive melanoma cells led to suppression of CDH13 promoter activity, whereas BRN2 knockdown in BRN2-positive/T-cadherin-negative cells resulted in re-expression of CDH13 mRNA and protein [85].